Legacy Wealth Management (Idaho)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3
Closed -$189 – 290
2026
Q1
$189 Hold
3
– – ﹤0.01% 992
2025
Q4
$287 Buy
+3
New +$294 ﹤0.01% 854

Other funds holding BSX

Legacy Wealth Management (Idaho)'s BSX Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3 shares — an estimated $189 sold.

Legacy Wealth Management (Idaho) first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $287 in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 3 Boston Scientific shares in Q2 2026, an estimated $189.
  • Legacy Wealth Management (Idaho) first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
  • Legacy Wealth Management (Idaho)'s Boston Scientific position peaked at $287 in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.